Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1)...

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Nayak-Kapoor, Asha, Hao, Zhonglin, Sadek, Ramses, Dobbins, Robin, Marshall, Lisa, Vahanian, Nicholas N., Jay Ramsey, W., Kennedy, Eugene, Mautino, Mario R., Link, Charles J., Lin, Ray S., Royer-Joo, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-018-0351-9
Date:
December, 2018
File:
PDF, 1.11 MB
english, 2018
Conversion to is in progress
Conversion to is failed